Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Strata Critical Medical, Inc.SRTA · Entity 5512 | Director | July 30, 2026 | August 03, 2026 |
| TripAdvisor, Inc.TRIP · Entity 4890 | Director | June 29, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Strata Critical Medical, Inc.
Report date July 30, 2026 · Filed August 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 5,325,896 |
Reported balance
After 2026-07-30 transaction · row 1
1 source rowRow 1 · 2026-07-30 · Grant · Acquired 50,234 · Balance 5,325,896 F1: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2027 Annual Meeting of Stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2027 Annual Meeting of Stockholders.
TripAdvisor, Inc.
Report date June 29, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 110,472 |
Reported balance
After 2026-06-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-29 · Grant · Acquired 17,818 · Balance 110,472 F1: Represents shares underlying restricted stock units ("RSUs") granted under the Tripadvisor, Inc. 2023 Stock and Annual Incentive Plan in connection with such individual's election to the Company's Board of Directors on June 29, 2026. Such RSUs vest in full on June 29, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares underlying restricted stock units ("RSUs") granted under the Tripadvisor, Inc. 2023 Stock and Annual Incentive Plan in connection with such individual's election to the Company's Board of Directors on June 29, 2026. Such RSUs vest in full on June 29, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Starz Acquisition LLC
Report date December 08, 2016 · Filed December 12, 2016
Section 16 reporting ended · disclosed 2016-12-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-12-08 transaction · row 1
1 source rowRow 1 · 2016-12-08 · Disposition to issuer · Disposed 14,891 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of June 30, 2016 (as amended, the "Merger Agreement"), by and among Starz, Lions Gate Entertainment Corp. ("Lions Gate"), and Orion Arm Acquisition Inc. ("Merger Sub"), an indirect wholly owned subsidiary of Lions Gate, on December 8, 2016, Merger Sub was merged with and into Starz, with Starz continuing as the surviving corporation and a wholly owned subsidiary of Lions Gate (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of Starz Series A common stock was converted into the right to receive $18.00 in cash and 0.6784 of a Class B non-voting share of Lions Gate. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of June 30, 2016 (as amended, the "Merger Agreement"), by and among Starz, Lions Gate Entertainment Corp. ("Lions Gate"), and Orion Arm Acquisition Inc. ("Merger Sub"), an indirect wholly owned subsidiary of Lions Gate, on December 8, 2016, Merger Sub was merged with and into Starz, with Starz continuing as the surviving corporation and a wholly owned subsidiary of Lions Gate (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of Starz Series A common stock was converted into the right to receive $18.00 in cash and 0.6784 of a Class B non-voting share of Lions Gate.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 30, 2026 Filed Aug 3, 2026 20:06 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 50,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-051819 · wk-form4_1785787608.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,325,896 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2027 Annual Meeting of Stockholders. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:23 UTC | TripAdvisor, Inc. TRIP · Entity 4890 | GrantCommon Stock | 17,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001526520-26-000136 · form4.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,472 F1 · security: Represents shares underlying restricted stock units ("RSUs") granted under the Tripadvisor, Inc. 2023 Stock and Annual Incentive Plan in connection with such individual's election to the Company's Board of Directors on June 29, 2026. Such RSUs vest in full on June 29, 2027. Read SEC document |
| August 29, 2025 Filed Sep 4, 2025 00:43 UTC | Strata Critical Medical, Inc. SRTA · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 40,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-25-000096 · wk-form4_1756946636.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,275,662 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2026 Annual Meeting of Stockholders. F2 · balance_after: Effective as of September 2, 2025, the terms of 886,886 unvested RSUs granted to the Reporting Person by the Issuer on November 9, 2022 and originally reported by the Reporting Person in Table I of a Form 4 filed on November 14, 2022 and 33,591 unvested RSUs granted to the Reporting Person by the Issuer on December 16, 2021 and originally reported by the Reporting Person in Table I of a Form 4 on December 20, 2021, were amended by the Issuer's board of directors to make them subject to an additional performance-related vesting condition. As a result of such amendment, the shares of the Issuer's common stock underlying such unvested RSUs will no longer be included in the securities beneficially owned by the Reporting Person as reflected in column 5 of Table I. Upon satisfaction of the relevant performance-related vesting condition, the Reporting Person will again report the acquisition of such shares on a Form 4. Read SEC document |
| August 06, 2025 Filed Aug 7, 2025 21:35 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 282,470 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-25-000085 · wk-form4_1754602528.xml · derivative · entry 2 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A common stock, $0.0001 par value per share · 282,470 shares Expires 2025-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2025 Filed Aug 7, 2025 21:35 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 282,470 | $0.18 | $50,844.60 |
DisclosureSEC source: 0001779128-25-000085 · wk-form4_1754602528.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,155,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 22:14 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 136,263 | $3.99 | $543,689.37 |
DisclosureSEC source: 0001779128-25-000078 · wk-form4_1754432086.xml · nonDerivative · entry 2 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,873,065 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 22:14 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 246,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-25-000078 · wk-form4_1754432086.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,009,328 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 22:08 UTC | TripAdvisor, Inc. TRIP · Entity 4890 | GrantCommon Stock | 19,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-017856 · form4.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,270 F1 · security: Represents shares underlying Deferred Restricted Stock Units ("DSUs") granted under the Tripadvisor, Inc. 2023 Stock and Annual Incentive Plan in connection with such individual's election to the Company's Board of Directors on June 18, 2025. Such DSUs vest in full on June 18, 2026; however, receipt of100% of the shares will be deferred until following termination of the Reporting Person's service as a Director. Read SEC document |
| June 18, 2025 Filed Jul 1, 2026 22:48 UTC Amendment | TripAdvisor, Inc. TRIP · Entity 4890 | GrantCommon Stock | 19,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001526520-26-000117 · form4a.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,654 F1 · balance_after: Due to an inadvertent error, the Form 4 filed on June 20, 2025 incorrectly reported the amount of securities beneficially owned following reported transactions. This inadvertent error caused the amount of securities beneficially owned to be overstated by 13,616 shares. The new amount reported in Column 5 reports the correct amount of securities beneficially owned. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:21 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 91,031 | $3.80 | $345,917.80 |
DisclosureSEC source: 0001779128-25-000053 · wk-form4_1749676900.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,762,899 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 27, 2025 Filed Mar 28, 2025 20:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 1,237,611 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-25-000026 · wk-form4_1743192145.xml · derivative · entry 3 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A common stock, $0.0001 par value per share · 1,237,611 shares Expires 2025-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2025 Filed Mar 28, 2025 20:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 717,815 | $2.98 | $2,139,088.70 |
DisclosureSEC source: 0001779128-25-000026 · wk-form4_1743192145.xml · nonDerivative · entry 2 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,853,930 F1 · shares: Represents shares withheld by the Issuer to satisfy the exercise price and tax withholding obligations in connection with the exercise of stock options. Read SEC document |
| March 27, 2025 Filed Mar 28, 2025 20:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 1,237,611 | $0.18 | $222,769.98 |
DisclosureSEC source: 0001779128-25-000026 · wk-form4_1743192145.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,571,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:24 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 91,213 | $3.12 | $284,584.56 |
DisclosureSEC source: 0001779128-25-000022 · wk-form4_1742243038.xml · nonDerivative · entry 3 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,334,134 F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:24 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 218,479 | $3.12 | $681,654.48 |
DisclosureSEC source: 0001779128-25-000022 · wk-form4_1742243038.xml · nonDerivative · entry 2 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,425,347 F2 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:24 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 394,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-25-000022 · wk-form4_1742243038.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,643,826 F1 · shares: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 21:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 1,237,612 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-24-000162 · wk-form4_1734988998.xml · derivative · entry 3 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,237,611 Underlying: Class A common stock, $0.0001 par value per share · 1,237,612 shares Expires 2025-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 21:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 709,933 | $3.90 | $2,768,738.70 |
DisclosureSEC source: 0001779128-24-000162 · wk-form4_1734988998.xml · nonDerivative · entry 2 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,249,540 F1 · shares: Represents shares withheld by the Issuer to satisfy the exercise price and tax withholding obligations in connection with the exercise of stock options. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 21:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 1,237,612 | $0.18 | $222,770.16 |
DisclosureSEC source: 0001779128-24-000162 · wk-form4_1734988998.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,959,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2024 Filed Dec 11, 2024 22:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 91,031 | $4.72 | $429,666.32 |
DisclosureSEC source: 0001779128-24-000152 · wk-form4_1733956637.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,721,861 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:39 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 2,100,000 | $3.22 | $6,762,000.00 |
DisclosureSEC source: 0001779128-24-000132 · wk-form4_1731699581.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,812,892 F1 · balance_after: Following the reported transactions, the number of shares of Class A Common Stock of the Issuer beneficially owned by the Reporting Person, 8,749,588 (inclusive of exercisable stock options and restricted stock units vesting with 60 days of the final transaction date), plus the number of shares of Class A Common Stock of the Issuer underlying the Reporting Person's outstanding unvested equity awards (inclusive of 1,971,428 unvested performance-based restricted stock units and 1,249,696 unvested time-based restricted stock units that are not vesting within 60 days of the reported transaction), is equal to 11,970,712 shares of Class A Common Stock of the Issuer in the aggregate. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 16:04 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 91,030 | $2.85 | $259,435.50 |
DisclosureSEC source: 0001779128-24-000118 · wk-form4_1726243487.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,912,892 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 21:22 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 145,571 | $2.94 | $427,978.74 |
DisclosureSEC source: 0001779128-24-000086 · wk-form4_1718659319.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,003,922 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 22:10 UTC | TripAdvisor, Inc. TRIP · Entity 4890 | GrantCommon Stock | 13,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-018631 · form4.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,483 F1 · security: Represents shares underlying Restricted Stock Units ("RSUs") granted under Tripadvisor, Inc. stock and annual incentive plan in connection with such individual's election to the Board of Directors on June 11, 2024. Such RSUs vest in full on June 11, 2025. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 20:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 25,418 | $3.28 | $83,315.12 |
DisclosureSEC source: 0001779128-24-000055 · wk-form4_1712348794.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,149,493 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.175 to $3.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 21:40 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 66,932 | $2.62 | $175,669.73 |
DisclosureSEC source: 0001779128-24-000036 · wk-form4_1710538826.xml · nonDerivative · entry 2 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,174,911 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 21:40 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 68,387 | $2.76 | $189,083.22 |
DisclosureSEC source: 0001779128-24-000036 · wk-form4_1710538826.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,241,843 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.655 to $2.875, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 22:01 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 45,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-24-000021 · wk-form4_1710280852.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,310,230 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. All of the RSUs will vest on April 1, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| December 15, 2023 Filed Dec 16, 2023 00:00 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 17,494 | $3.22 | $56,306.19 |
DisclosureSEC source: 0001779128-23-000141 · wk-form4_1702684814.xml · nonDerivative · entry 3 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,264,558 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.10 to $3.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| December 14, 2023 Filed Dec 16, 2023 00:00 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 41,396 | $3.20 | $132,620.37 |
DisclosureSEC source: 0001779128-23-000141 · wk-form4_1702684814.xml · nonDerivative · entry 2 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,282,052 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.12 to $3.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| December 13, 2023 Filed Dec 16, 2023 00:00 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 37,365 | $2.95 | $110,163.23 |
DisclosureSEC source: 0001779128-23-000141 · wk-form4_1702684814.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,323,448 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.80 to $3.0750, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 06, 2023 Filed Oct 6, 2023 23:25 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 37,307 | $2.40 | $89,458.46 |
DisclosureSEC source: 0001779128-23-000108 · wk-form4_1696634732.xml · nonDerivative · entry 3 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,360,813 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.335 to $2.435, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 05, 2023 Filed Oct 6, 2023 23:25 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 28,892 | $2.41 | $69,690.39 |
DisclosureSEC source: 0001779128-23-000108 · wk-form4_1696634732.xml · nonDerivative · entry 2 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,398,120 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.375 to $2.505, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 23:25 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 34,552 | $2.51 | $86,749.71 |
DisclosureSEC source: 0001779128-23-000108 · wk-form4_1696634732.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,427,012 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.495 to $2.575, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 22:49 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 81,326 | $3.88 | $315,902.71 |
DisclosureSEC source: 0001779128-23-000067 · wf-form4_168902933482322.xml · nonDerivative · entry 3 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,461,564 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.81 to $3.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 22:49 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 62,954 | $3.82 | $240,597.60 |
DisclosureSEC source: 0001779128-23-000067 · wf-form4_168902933482322.xml · nonDerivative · entry 2 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,542,890 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 22:49 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 63,652 | $3.75 | $238,765.02 |
DisclosureSEC source: 0001779128-23-000067 · wf-form4_168902933482322.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,605,844 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.605 to $3.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:51 UTC | TripAdvisor, Inc. TRIP · Entity 4890 | GrantCommon Stock | 15,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-018342 · form4.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,867 F1 · security: Represents shares underlying Restricted Stock Units ("RSUs") granted under Tripadvisor, Inc. stock and annual incentive plan in connection with such individual's election to the Board of Directors on June 6, 2023. Such RSUs vest in full on June 6, 2024. Read SEC document |
| April 10, 2023 Filed Apr 11, 2023 21:09 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 49,336 | $2.83 | $139,793.56 |
DisclosureSEC source: 0001779128-23-000038 · wf-form4_168124736196059.xml · nonDerivative · entry 3 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,669,496 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.805 to $2.935, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 06, 2023 Filed Apr 11, 2023 21:09 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 25,047 | $2.92 | $73,019.52 |
DisclosureSEC source: 0001779128-23-000038 · wf-form4_168124736196059.xml · nonDerivative · entry 2 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,718,832 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.87 to $3.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 05, 2023 Filed Apr 11, 2023 21:09 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 32,514 | $2.98 | $96,826.69 |
DisclosureSEC source: 0001779128-23-000038 · wf-form4_168124736196059.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,743,879 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.825 to $3.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| January 09, 2023 Filed Jan 12, 2023 15:31 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 10,874 | $3.47 | $37,776.28 |
DisclosureSEC source: 0001779128-23-000014 · wf-form4_167353745213502.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,776,393 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.42 to $3.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 15:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 2,365,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-22-000119 · wf-form4_166843812976516.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,787,267 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 6.25% (rounded down to the nearest whole number) will vest on the first day of every calendar quarter following January 1, 2023 (with the first tranche to vest on April 1, 2023), with any remaining unvested RSUs to vest on January 1, 2027, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| October 06, 2022 Filed Oct 11, 2022 14:15 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 9,454 | $3.97 | $37,540.89 |
DisclosureSEC source: 0001779128-22-000099 · wf-form4_166549772960240.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,422,239 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.97 to $4.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 15, 2022 Filed Aug 8, 2022 14:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 9,289 | $4.41 | $40,964.49 |
DisclosureSEC source: 0001779128-22-000073 · wf-form4_165996880539937.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,431,693 Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 21:56 UTC | TripAdvisor, Inc. TRIP · Entity 4890 | GrantCommon Stock | 12,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017652 · form4.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,762 F1 · security: Represents shares underlying RSUs granted under the Issuer's 2018 Stock and Annual Incentive Plan in connection with such individual's election to the Issuer's Board of Directors on June 14, 2022. Such RSUs vest in full on June 14, 2023. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 14:34 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 9,236 | $8.60 | $79,429.60 |
DisclosureSEC source: 0001779128-22-000027 · wf-form4_164925564011193.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,440,982 Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 16:29 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 268,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-21-000017 · wf-form4_164001777439831.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450,218 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 6.25% (rounded down to the nearest whole number) will vest every three calendar months from January 1,2022 (with the first tranche to vest on April 1, 2022), with any remaining unvested Restricted Stock Units to vest on January 1, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 23:24 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 36,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-21-000009 · wf-form4_163969703758068.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,181,490 Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 22:04 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 295,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-007695 · form4.xml · nonDerivative · entry 1 WIESENTHAL ROBERT S · CIK 0001211785 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,218,459 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 66.67% of the RSUs will vest on July 1, 2023, and the remaining RSUs will vest on July 1, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.